ask="1.2000"
ask_size="500"
average_daily_volume="80550"
bid="1.1300"
bid_size="800"
book_value="0.7250"
change="+0.0299"
change_from_200_day_moving_average="-0.2487"
change_from_50_day_moving_average="-0.1265"
change_from_52_week_high="-0.8601"
change_From_52_week_low="0.2099"
change_in_percent="+2.6937%"
close="1.1399"
dividend_pay_date="11/8/2012"
dividend_per_share="0.0000"
dividend_yield="0.0000"
earnings_per_share="-0.8100"
ebitda="-30.65M"
eps_estimate_current_year="-0.8500"
eps_estimate_next_quarter="-0.2000"
eps_estimate_next_year="-0.8600"
ex_dividend_date="11/9/2012"
float_shares="30545000"
high="1.1700"
high_52_weeks="2.0000"
last_trade_date="2/7/2017"
last_trade_price="1.1399"
last_trade_size="346"
last_trade_time="3:57pm"
low="1.1200"
low_52_weeks="0.9300"
market_capitalization="44.05M"
moving_average_200_day="1.3886"
moving_average_50_day="1.2664"
name="Aviragen Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.1700"
open="1.1200"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-17.9107%"
percent_change_from_50_day_moving_average="-9.9861%"
percent_change_from_52_week_high="-43.0050%"
percent_change_from_52_week_low="+22.5699%"
previous_close="1.1100"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.5310"
price_per_sales="4.3766"
revenue="9.80M"
shares_outstanding="38640000"
short_ratio="1.2600"
stock_exchange="NMS"
symbol="AVIR"
volume="39308"
weeks_range_52="0.9300 - 2.0000"
